Ota, Yuki
Obata, Yoko
Takazono, Takahiro
Tashiro, Masato
Wakamura, Tomotaro
Takahashi, Akinori
Shiozawa, Yui
Miyazaki, Taiga
Nishino, Tomoya
Izumikawa, Koichi
Article History
Received: 8 February 2021
Accepted: 15 June 2021
First Online: 30 June 2021
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki. The data herein were anonymously processed by the database provider in accordance with the Act on the Protection of Personal Information of Japan and other related regulations. For the usage of unlinkable de-identified data, ethical approval and informed consent were waived according to the Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects by the Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labour, and Welfare of Japan. The study received ethical approval from Nagasaki University School of Medicine Research Ethics Committee (approval number 18033038–5).
: Not applicable.
: K.I. received honorarium and research grant from Sumitomo Dainippon Pharma Co., Ltd. T.W. is a full-time employee of Sumitomo Dainippon Pharma Co., Ltd. A.T. and Y.S. are full-time employees of Deloitte Tohmatsu Consulting LLC. Deloitte Tohmatsu Consulting LLC receives consulting fees from Sumitomo Dainippon Pharma Co., Ltd. Other authors do not have any competing interest.